In October 2022, the Company group's research and development (R&D) organization transitioned to the Deep Human Biology Learning (DHBL) drug discovery and development. Under the DHBL drug discovery ...
The latest announcement is out from Chugai Pharmaceutical Co ( ($JP:4519) ). Chugai Pharmaceutical has completed the process of making Renalys ...
(Note) As the Merger falls under a simplified absorption-type merger as prescribed in the Article 796, Paragraph 2 of the Companies Act in Japan for IIJ and a short-form merger as prescribed in the ...
TipRanks on MSN
BIPROGY Inc. announces absorption merger with subsidiary for operational streamlining
An announcement from BIPROGY Inc. ( ($JP:8056) ) is now available. BIPROGY Inc. has announced the absorption-type merger of its wholly owned ...
CICC (03908.HK) announced that the company, and Dongxing Securities and Cinda Securities further entered into the Merger Agreement today (December 17) with respect to the Proposed ... CICC (03908.HK) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback